This site is intended for healthcare professionals
News

scPharmaceuticals Inc. has resubmitted its NDA to the FDA for Furoscix for the treatment of congestion in patients with heart failure.

Read time: 1 mins
Last updated:2nd Jul 2020
Published:2nd Jul 2020
Condition: Heart Failure
Type: drug
Register free for full access to medthority.com